Nasal Lymphomas in Japan: A High Prevalence of Epstein-Barr Virus Type A and Deletion Within the Latent Membrane Protein Gene

References

• Weiss L. M., Gaffey M. J., Chen Y. Y., Frierson H. F., Jr. Frequency of Epstein-Barr viral DNA in “Western” sinonasal and Waldeyer's ring non-Hodgkin's lymphomas. Am. J. Surg. Pathol. 1992; 16: 156–162
   PubMed Web of Science ®Google Scholar
• van Gorp J., Weiping L., Jacobse K., Liu Y. H., Li F. Y., De Weger R. A., Li G. Epstein-Barr virus in nasal T-cell lymphomas (polymorphic reticulosis/midline malignant reticulosis) in western China. J. Pathol. 1994; 173: 81–87
   PubMed Web of Science ®Google Scholar
• Tao Q., Ho F. C., Loke S. L., Srivastava G. Epstein-Barr virus is localized in the tumour cells of nasal lymphomas of NK. T or B cell type. Int. J. Cancer 1995; 60(3)315–320
   PubMed Web of Science ®Google Scholar
• Ng C. S., Chan J. K., Lo S T. Expression of natural killer cell markers in non-Hodgkin's lymphomas. Hum. Pathol. 1987; 18: 1257–1262
   PubMed Web of Science ®Google Scholar
• Medeiros L. J., Jaffe E. S., Chen Y. Y., Weiss L. M. Localization of Epstein-Barr viral genomes in angiocentric immunoproliferative lesions. Am. J. Surg. Pathol. 1992; 16: 439–447
   PubMed Web of Science ®Google Scholar
• Kobashi Y., Nakamura S., Sasajima Y., Koshikawa T., Yatabe Y., Kitoh K., Mori S., Ueda R., Yamabe H., Suchi T. Inconsistent association of Epstein-Barr virus with CD56 (NCAM)-positive angiocentric lymphoma occuring in sites other than the upper and lower respiratory tract. Histopathology 1996; 28: 111–120
   PubMed Web of Science ®Google Scholar
• Petrella T., Delfau M. H. Larue, Caillot D., Morcillo J. L., Casasnovas O., Portier H., Gaulard P., Farcet J. P., Arnould L. Nasopharyngeal lymphomas: further evidence for a natural killer cell origin. Hum. Pathol. 1996; 27: 827–833
   PubMed Web of Science ®Google Scholar
• Suzumiya J., Takeshita M., Kimura N., Kikuchi M., Uchida T., Hisano S., Eura Y., Kozuru M., Nomura Y., Tomita K., Komiyama S., Okumura M. Expression of adult and fetal natural killer cell markers in sinonasal lymphomas. Blood 1994; 83: 2255–2260
   PubMed Web of Science ®Google Scholar
• Ho F. C., Choy D., Loke S. L., Kung I. T., Fu K. H., Liang R., Todd D., Khoo R. K. Polymorphic reticulosis and conventional lymphomas of the nose and upper aerodigestive tract: a clinicopathologic study of 70 cases, and immunophenotypic studies of 16 cases. Hum. Pathol. 1990; 21: 1041–1050
   PubMed Web of Science ®Google Scholar
• Ho F. C., Srivastava G., Loke S. L., Fu K. H., Leung B. P., Liang R., Choy D. Presence of Epstein-Barr virus DNA in nasal lymphomas of B and 'T' cell type. Hematol. Oncol. 1990; 8: 271–281
   PubMed Web of Science ®Google Scholar
• Harabuchi Y., Yamanaka N., Kataura A., Imai S., Kinoshita T., Mizuno F., Osato T. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990; 335: 128–130
   PubMed Web of Science ®Google Scholar
• Emile J. F., Boulland M. L., Haioun C., Kanavaros P., Petrella T., Delfau M. H. Larue, Bensussan A., Farcet J. P., Gaulard P. CD5-CD56+ T-cell receptor silent peripheral T-cell lymphomas are natural killer cell lymphomas. Blood 1996; 87: 1466–1473
   PubMed Web of Science ®Google Scholar
• Kanavaros P., Lescs M. C., Briere J., Divine M., Galateau F., Joab I., Bosq J., Farcet J. P., Reyes F. Nasal T-cell lymphoma: a clinicopathologic entity associated with peculiar phenotype and with Epstein-Barr virus. Blood 1993; 81: 2688–2695
   PubMed Web of Science ®Google Scholar
• Borisch B., Hennig I., Laeng R. H., Waelti E. R., Kraft R., Laissue J. Association of the subtype 2 of the Epstein-Barr virus with T-cell non-Hodgkin's lymphoma of the midline granuloma type. Blood 1993; 82: 858–864
   PubMed Web of Science ®Google Scholar
• Chan J. K., Yip T. T., Tsang W. Y., Ng C. S., Lau W. H., Poon Y. F., Wong C. C., Ma V. W. Detection of Epstein-Barr viral RNA in malignant lymphomas of the upper aerodigestive tract. Am. J. Surg. Pathol. 1994; 18: 938–946
   PubMed Web of Science ®Google Scholar
• Suzumiya J., Takeshita M., Kimura N., Kikuchi M. TCR-CD56+CD2+nasal lymphomas with membrane-localized CD3 positivity: Are the CD3+ cells neoplastic or reactive?; Response. Blood 1995; 85: 2994–2996
   Web of Science ®Google Scholar
• Nakamura S., Katoh E., Koshikawa T., Yatabe Y., Nagasaka T., Ishida H., Tokoro Y., Koike K., Kagami Y., Ogura M., Kojima M., Nara Y., Mizoguchi Y., Hara K., Kurita S., Seto M., Suchi T. Clinicopathologic study of nasal T/NK-cell lymphoma among the Japanese. Pathol. Int. 1997; 47: 38–53
   PubMed Web of Science ®Google Scholar
• Jaffe E. S. Classification of natural killer (NK) cell and NK-like T-cell malignancies. Blood 1996; 87: 1207–1210
   PubMed Web of Science ®Google Scholar
• Chiang A. K., Chan A. C., Srivastava G., Ho F. C. Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage. Int. J. Cancer 1997; 73: 332–338
   PubMed Web of Science ®Google Scholar
• Aozasa K., Ohsawa M., Tajima K., Sasaki R., Maeda H., Matsunaga T., Friedmann I. Nation-wide study of lethal mid-line granuloma in Japan: frequencies of Wegener's granulomatosis, polymorphic reticulosis, malignant lymphoma and other related conditions. Int. J. Cancer 1989; 44: 63–66
   PubMed Web of Science ®Google Scholar
• Arber D. A., Weiss L. M., Albujar P. F., Chen Y. Y., Jaffe E. S. Nasal lymphomas in Peru. High incidence of T-cell immunophenotype and Epstein-Barr virus infection [see comments]. Am. J. Surg. Pathol. 1993; 17: 392–399
   PubMed Web of Science ®Google Scholar
• Campo E., Cardesa A., Alos L., Palacin A., Cobarro J., Traserra J., Montserrat E. Non-Hodgkin's lymphomas of nasal cavity and paranasal sinuses. An immunohistochemical study. Am. J. Clin. Pathol. 1991; 96: 184–190
   PubMed Web of Science ®Google Scholar
• Abbondanzo S. L., Wenig B. M. Non-Hodgkin's lymphoma of the sinonasal tract. A clinicopathologic and immunophenotypic study of 120 cases. Cancer 1995; 75: 1281–1291
   PubMed Web of Science ®Google Scholar
• Fellbaum C., Hansmann M. L., Lennert K. Malignant lymphomas of the nasal cavity and paranasal sinuses. Virchows Arch. A Pathol. Anat. Histopathol. 1989; 414: 399–405
   PubMedGoogle Scholar
• Ferry J. A., Sklar J., Zukerberg L. R., Harris N. L. Nasal lymphoma. A clinicopathologic study with immunophenotypic and genotypic analysis. Am. J. Surg. Pathol. 1991; 15: 268–279
   PubMed Web of Science ®Google Scholar
• Tomita Y., Ohsawa M., Mishiro Y., Kubo T., Maeshiro N., Kojya S., Noda Y., Aozasa K. The presence and subtype of Epstein-Barr virus in B and T cell lymphomas of the sino-nasal region from the Osaka and Okinawa districts of Japan. Lab. Invest. 1995; 73: 190–196
   PubMed Web of Science ®Google Scholar
• Young L. S., Yao Q. Y., Rooney C. M., Sculley T. B., Moss D. J., Rupani H., Laux G., Bornkamm G. W., Rickinson A. B. New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas. J. Gen. Virol. 1987; 68: 2853–2862
   PubMed Web of Science ®Google Scholar
• Sandvej K., Peh S. C., Andresen B. S., Pallesen G. Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30-bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 1994; 184: 4053–4060
   Google Scholar
• Knecht H., Bachmann E., Brousset P., Sandvej K., Nadal D., Bachmann F., Odermatt B. F., Delsol G., Pallesen G. Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 1993; 82: 2937–2942
   PubMed Web of Science ®Google Scholar
• Knecht H., Bachmann E., Joske D. J., Sahli R., Emery A. Goodman, Casanova J. L., Zilic M., Bachmann F., Odermatt B. F. Molecular analysis of the LMP (latent membrane protein) oncogene in Hodgkin's disease. Leukemia 1993; 7: 580–585
   PubMed Web of Science ®Google Scholar
• Knecht H., Bachmann E., Brousset P., Rothenberger S., Einsele H., Lestou V. S., Delsol G., Bachmann F., Ambros P. F., Odermatt B. P. Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders. Oncogene 1995; 10: 523–528
   PubMed Web of Science ®Google Scholar
• Chen M. L., Tsai C. N., Liang C. L., Shu C. H., Huang C. R., Sulitzeanu D., Liu S. T., Chang Y. S. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 1992; 7: 2131–140
   PubMed Web of Science ®Google Scholar
• Ohshima K., Takeo H., Kikuchi M., Kozuru M., Uike N., Masuda Y., Yoneda S., Takeshita M., Shibata T., Akamatsu M. Heterogeneity of Epstein-Barr virus infection in angioimmunoblastic lymphadenopathy type T-cell lymphoma. Histopathol. 1994; 25: 569–579
   PubMed Web of Science ®Google Scholar
• Ohshima K., Suzumiya J., Tasiro K., Mukai Y., Tanaka T., Kato A., Kikuchi M. Epstein-Barr virus infection and associated products (LMP, EBNA2, vIL-10) in nodal non-Hodgkin's lymphoma of human immunodeficiency virus-negative Japanese. Am. J. Hematol. 1996; 52: 21–28
   PubMed Web of Science ®Google Scholar
• Weiss L. M., Jaffe E. S., Liu X. R., Chen Y. Y., Shibata D., Medeiros L. J. Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood 1992; 79: 1789–1795
   PubMed Web of Science ®Google Scholar
• Saito I., Servenius B., Compton T., Fox R. I. Detection of Epstein-Barr virus DNA by polymerase chain reaction in blood and tissue biopsies from patients with Sjogren's syndrome. J. Exp. Med. 1989; 169: 2191–2198
   PubMed Web of Science ®Google Scholar
• Boyle M. J., Vasak E., Tschuchnigg M., Turner J. J., Sculley T., Penny R., Cooper D. A., Tindall B., Sewell W. A. Subtypes of Epstein-Barr virus (EBV) in Hodgkin's disease: association between B-type EBV and immunocompromise. Blood 1993; 81: 468–474
   PubMed Web of Science ®Google Scholar
• Chen W. G., Chen Y. Y., Bacchi M. M., Bacchi C. E., Alvarenga M., Weiss L. M. Genotyping of Epstein-Barr virus in Brazilian Burkitt's lymphoma and reactive lymphoid tissue. Type A with a high prevalence of deletions within the latent membrane protein gene. Am. J. Pathol. 1996; 148: 17–23
   PubMed Web of Science ®Google Scholar
• Koita H., Suzumiya J., Ohshima K., Takeshita M., Kimura N., Kikuchi M., Koono M. Lymphoblastic lymphoma expressing natural killer cell phenotype with involvement of the mediastinum and nasal cavity. Am. J. Surg. Pathol. 1997; 21: 242–248
   PubMed Web of Science ®Google Scholar
• Suzumiya J., Takeshita M., Kimura N., Morioka E., Sakai T., Hisano S., Okumura M., Kikuchi M. Sinonasal malignant lymphoma of natural killer cell phenotype associated with diffuse pancreatic involvement. Leuk. Lymphoma. 1993; 10: 231–236
   PubMed Web of Science ®Google Scholar
• Yamanaka N., Harabuchi Y., Sambe S., Shido F., Matsuda F., Kataura A., Ishii Y., Kikuchi K. Non-Hodgkin's lymphoma of Waldeyer's ring and nasal cavity. Clinical and immunologic aspects. Cancer 1985; 56: 768–576
   PubMed Web of Science ®Google Scholar
• Chan J. K., Ng C. S., Lau W. H., Lo S. T. Most nasal/nasopharyngeal lymphomas are peripheral T-cell neoplasms. Am. J. Surg. Pathol. 1987; 11: 418–429
   PubMed Web of Science ®Google Scholar
• Tomita Y., Ohsawa M., Qiu K., Hashimoto M., Yang W. I., Kim G. E., Aozasa K. Epstein-Barr virus in lymphoproliferative diseases in the sino-nasal region: close association with CD56+ immunophenotype and polymorphic-reticulosis morphology. Int. J. Cancer 1997; 70: 9–13
   PubMed Web of Science ®Google Scholar
• Ohshima K., Suzumiya J., Kanda M., Kato A., Kikuchi M. Integrated and episomal forms of Epstein-Barr virus (EBV) in EBV associated disease. Cancer Lett. 1998; 122: 43–50
   PubMed Web of Science ®Google Scholar
• Zimber U., Adldinger H. K., Lenoir G. M., Vuillaume M., Knebel M. V. Doeberitz, Laux G., Desgranges C., Wittmann P., Freese U. K., Schneider U., et al. Geographical prevalence of two types of Epstein-Barr virus. Virology 1986; 154: 56–66
   PubMed Web of Science ®Google Scholar
• Sixbey J. W., Shirley P., Chesney P. J., Buntin D. M., Resnick L. Detection of a second widespread strain of Epstein-Barr virus. Lancet 1989; 2(8666)761–765
   PubMed Web of Science ®Google Scholar
• Borisch B., Finke J., Hennig I., Delacretaz F., Schneider J., Heitz P. U., Laissue J. A. Distribution and localization of Epstein-Barr virus subtypes A and B in AIDS-related lymphomas and lymphatic tissue of HIV-positive patients. J. Pathol. 1992; 168: 229–236
   PubMed Web of Science ®Google Scholar
• Boyle M. J., Sewell W. A., Sculley T. B., Apolloni A., Turner J. J., Swanson C. E., Penny R., Cooper D. A. Subtypes of Epstein-Barr virus in human immunodeficiency virus-associated non-Hodgkin lymphoma. Blood 1991; 78: 3004–3011
   PubMed Web of Science ®Google Scholar
• Kingma D. W., Weiss W. B., Jaffe E. S., Kumar S., Frekko K., Raffeld M. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 1996; 88: 242–251
   PubMed Web of Science ®Google Scholar
• Henderson S., Rowe M., Gregory C., Croom D. Carter, Wang F., Longnecker R., Kieff E., Rickinson A. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991; 65: 1107–1115
   PubMed Web of Science ®Google Scholar